Improvement of awareness, treatment and control of hypertension among chronic kidney disease patients in China from 1999 to 2005

Hypertension Research

Volumn 32, Issue 6, 2009, Pages 444-449

  Wang, Yu ^a,b   Zhang, Luxia ^a,b   Li, Xiaomei ^a,b   Xu, Yulan ^c   Yang, Min ^d   Qian, Jiaqi ^e   Wang, Lining ^f   Chen, Nan ^g   Gu, Yong ^h   Chen, Mangmang ⁱ   Xing, Changying ^j   Chen, Xiangmei ^k   Hou, Fanfan ^l   Yu, Xueqing ^m   Cheng, Xiaomiao ⁿ   Guo, Lanzhong ^o   Wei, Chongyi ⁿ   Huang, Guodong ^p   Zhang, Qing ^q   Wang, Rong ^r   Wang, Li ^s   Mei, Changlin ^t   Li, Youyun ^u   Liu, Zhihong ^v   Zhao, Liancheng ^w   Wu, Yangfeng ^x   Wang, Hai Yan ^a,b   more..

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b BEIJING HOSPITAL   (China)

^c Wen Zhou University   (China)

^d Department of Nephrology   (China)

^e SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^f CHINA MEDICAL UNIVERSITY   (China)

^g SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^h FUDAN UNIVERSITY   (China)

ⁱ An Gang Tie Dong Hospital   (China)

^j NANJING MEDICAL UNIVERSITY   (China)

^k CHINESE PLA GENERAL HOSPITAL   (China)

^l SOUTHERN MEDICAL UNIVERSITY   (China)

^m SUN YAT SEN UNIVERSITY   (China)

ⁿ CENTRAL SOUTH UNIVERSITY   (China)

^o Dong Yang Chinese Taditional Medicine Hospital   (China)

^p Hospital of Guang Xi Chinese Traditional Medicine College   (China)

^q YANTAI YUHUANGDING HOSPITAL   (China)

^r SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^s Sichuan University   (China)

^t SECOND MILITARY MEDICAL UNIVERSITY   (China)

^u SOUTHWEST MEDICAL UNIVERSITY   (China)

^v NANJING GENERAL HOSPITAL OF NANJING MILITARY COMMAND   (China)

^w FUWAI HOSPITAL   (China)

^x PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; ATTITUDE TO HEALTH; AWARENESS; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CHINA; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH EDUCATION; HEALTH SURVEY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; QUESTIONNAIRE; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGED; CHINA; FEMALE; GLOMERULAR FILTRATION RATE; HEALTH CARE SURVEYS; HEALTH EDUCATION; HEALTH SURVEYS; HOSPITALS; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; PHYSICIANS, FAMILY; SEX FACTORS; SOCIOECONOMIC FACTORS;

EID: 68249150863     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.38     Document Type: Article

References (28)

1. Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG, Schneider KA. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-Up Program Cooperative Group. Hypertension 1989; 13 (Suppl 5): 180-493.
2. Walker WG, Neaton JD, Cutler JA, Neuwirth R, Cohen JD. Renal function change in hypertensive members of the Multiple Risk factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. J Am Med Assoc 1992; 268: 3085-3091.
3. Ruggenenti P, Perna A, Gherardi G, Benini R, Remuzzi G. Chronic proteinuric nephropathies: Outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury. Am J Kidney Dis 2000; 35: 1155-1165.
4. Garg AX, Clark WF, Haynes RB, House AA. Moderate renal insufficiency and the risk of cardiovascular mortality: Results from the NHANES 1. Kidney Int 2002; 61: 1486-1494.
5. Cinotti GA, Comunian C. Hypertension and renal disease. Ren Fail 1993; 15: 373-377.
6. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993; 329: 1456-1462.
7. Lewis JB, Berl T, Bain RP, Rohde RD, Lewis EJ. Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group. Am J Kidney Dis 1999; 34: 809-817.
8. Parving HH, Rossing P. The use of antihypertensive agents in prevention and treatment of diabetic nephropathy. Curr Opin Nephrol Hypertens 1994; 3: 292-300.
9. Parving HH. Benefits and cost of antihypertensive treatment in incipient and overt diabetic nephropathy. J Hypertens Suppl 1998; 16: S99-S101.
10. Ruggenenti P, Perna A, Gherardi G, Gaspari F, Benini R, Remuzzi G. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Lancet 1998; 352: 1252-1256.
11. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 1995; 123: 754-762.
12. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S, RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345 861-869.
13. Curtis BM, Levin A, Parfrey PS. Multiple risk factor intervention in chronic kidney disease: Control of cardiac disease in chronic kidney disease patients. Med Clin North Am 2005; 89: 511-523.
14. Ruilope LM, Salvetti A, Jamerson K, Hansson L, Warnold I, Nedel H, Zanchetti A. Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol 2001; 12: 218-225.
15. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Ménard J, Rahn KH, Wedel H, Westerling S. Effects of intensive blood pressure lowering and low dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755-1762.
16. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, Jones DW, Materson BJ, Oparil S, Wright Jr JT, Roccella EJ, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
17. Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004; 43(Suppl 1): S1-S290.
18. Sarafidis PA, Li S, Chen SC, Collins AJ, Brown WW, Klag MJ, Bakris GL. Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med 2008; 121: 332-340.
19. De Nicola L, Minutolo R, Gallo C, Zoccali C, Cianciaruso B, Conte M, Lupo A, Fuiano G, Gallucci M, Bonomini M, Chiodini P, Signoriello G, Bellizzi V, Mallamaci F, Nappi F, Conte G. Management of hypertension in chronic kidney disease: The Italian multicentric study. J Nephrol 2005; 18: 397-404.
20. Coresh J, Wei GL, McQuillan G, Brancati FL, Levey AS, Jones C, Klaq MJ. Prevalence of high blood pressure and elevated serum creatinine level in the United States: Findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 2001; 161: 1207-1216.
21. Kidney Disease Outcome Quality Initiative. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation classification stratification. Am J Kidney Dis 2002; 39(Suppl 2): S1-S246.
22. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, Wang M, Xu GB, Wang HY. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006; 17; 2937-2944.
23. Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH. Chronic kidney disease awareness, prevalence, and trends among US adults, 1999-2000. J Am Soc Nephrol 2005; 16: 180-188.
24. Zhang LX, Zuo L, Xu GB, Wang F, Wang M, Wang S, Lv J, Liu L, Wang H. Community-based screening for chronic kidney disease among population older than 40 years in Beijing. Nephrol Dial Transplant 2007; 22: 1093-1099.
25. Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med 2006; 354: 997-999.
26. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 1995; 123: 754-762.
27. Wright Jr JT, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. J Am Med Assoc 2002; 288; 2421-2431.
28. Parikh NI, Hwang SJ, Larson MG, Meigs JB, Levy D, Fox CS. Cardiovascular disease risk factors in chronic kidney disease: Overall burden and rates of treatment and control. Arch Intern Med 2006; 166: 1884-1891.